Study OAS ·
Russia Develops New Cancer Vaccine 'Enteromix'
- Russia has announced the development of a new mRNA-based cancer vaccine named "Enteromix", which has reportedly shown high efficacy and safety in preclinical trials.
- The vaccine is initially intended for the treatment of colorectal cancer, with research underway for its application against glioblastoma (a type of brain cancer) and melanoma.
- The announcement was made by the head of Russia’s Federal Medical and Biological Agency (FMBA) at a recent international forum, stating that the vaccine is now "ready for use" and awaiting official regulatory approval.
Enteromix Vaccine Development
- Technology:
- Reported as an mRNA-based vaccine (similar to COVID-19 vaccines) and/or using four non-pathogenic viruses to attack tumors and activate the immune response.
- Designed to be personalized, tailored to individual patient’s RNA or tumor profile.
- Efficacy Claims:
- Preclinical trials showed 60–80% tumor reduction and improved survival, with some sources claiming 100% efficacy in early trials (though this is unverified and debated).
- Also being developed for glioblastoma (aggressive brain cancer) and melanoma.
- Trial Status:
- Preclinical trials completed over three years.
- Phase I clinical trials (human safety trials) have reportedly begun with 48 volunteers, showing low toxicity.
- Not yet approved for widespread clinical use; regulatory clearance pending.
Additional Info
- mRNA Vaccines:
- Messenger RNA (mRNA) vaccines represent a new type of vaccine.
- Instead of using a weakened or inactive germ, they teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies.
- This immune response then produces antibodies, which protect us from getting infected if the real virus enters our bodies.
- Cancer Immunotherapy:
- This is a type of cancer treatment that helps your immune system fight cancer.
- It works by stimulating or restoring the immune system's ability to recognize and destroy cancer cells.
- Types of immunotherapy include monoclonal antibodies, oncolytic virus therapy, and cancer vaccines.
- Regulatory Process for Vaccines:
- Vaccines typically undergo three phases of clinical trials to ensure they are safe and effective.
- Phase I: Involves a small group of people to test safety and side effects.
- Phase II: Administered to a larger group to evaluate effectiveness and further assess safety.
- Phase III: Given to thousands of people to confirm efficacy, monitor for rare side effects, and compare with existing treatments.
- After trials, the vaccine requires regulatory approval from national health authorities before it can be used by the public.